Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Food Chem ; 272: 679-687, 2019 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-30309598

RESUMEN

Nonenzymatic glycosylation (NEG) can generate advanced glycation end products (AGEs) and its intermediates α-dicarbonyl compounds, which contribute to the risk of diabetes. This study investigated the anti-glycation mechanisms and structure-activity relationship of (+)-catechin (CC) and (-)-epicatechin (EC). The results showed that the effect of CC on inhibiting AGEs was significantly better than that of EC (p < 0.05). By exploring the mechanism, we found that there was no significant difference in the ability of CC and EC to capture α-dicarbonyl compounds. But CC was found to be more efficient than EC to inhibit RO, OH and CHO radicals generation, which may be the primary reason that CC was more effective than EC on AGEs inhibition. What's more, CC showed better inhibitory effect on ß-glucosidase that was close to the molecular docking study. Our results will provide a theoretical foundation for development of different structure of procyanidins as natural AGEs inhibitors in food and medicine.


Asunto(s)
Biflavonoides/química , Catequina/química , Productos Finales de Glicación Avanzada/química , Proantocianidinas/química , Biflavonoides/metabolismo , Sitios de Unión , Catequina/metabolismo , Cromatografía Líquida de Alta Presión , Productos Finales de Glicación Avanzada/metabolismo , Glioxal/química , Humanos , Simulación del Acoplamiento Molecular , Proantocianidinas/metabolismo , Estructura Terciaria de Proteína , Relación Estructura-Actividad , Espectrometría de Masas en Tándem , alfa-Amilasas/antagonistas & inhibidores , alfa-Amilasas/metabolismo , beta-Glucosidasa/antagonistas & inhibidores , beta-Glucosidasa/metabolismo
2.
Part Fibre Toxicol ; 14(1): 40, 2017 10 13.
Artículo en Inglés | MEDLINE | ID: mdl-29029643

RESUMEN

BACKGROUND: Engineered nanomaterials (ENMs) are increasingly added to foods to improve their quality, sensory appeal, safety and shelf-life. Human exposure to these ingested ENMs (iENMS) is inevitable, yet little is known of their hazards. To assess potential hazards, efficient in vitro methodologies are needed to evaluate particle biokinetics and toxicity. These methodologies must account for interactions and transformations of iENMs in foods (food matrix effect) and in the gastrointestinal tract (GIT) that are likely to determine nano-biointeractions. Here we report the development and application of an integrated methodology consisting of three interconnected stages: 1) assessment of iENM-food interactions (food matrix effect) using model foods; 2) assessment of gastrointestinal transformations of the nano-enabled model foods using a three-stage GIT simulator; 3) assessment of iENMs biokinetics and cellular toxicity after exposure to simulated GIT conditions using a triculture cell model. As a case study, a model food (corn oil-in-water emulsion) was infused with Fe2O3 (Iron(III) oxide or ferric oxide) ENMs and processed using this three-stage integrated platform to study the impact of food matrix and GIT effects on nanoparticle biokinetics and cytotoxicity . METHODS: A corn oil in phosphate buffer emulsion was prepared using a high speed blender and high pressure homogenizer. Iron oxide ENM was dispersed in water by sonication and combined with the food model. The resulting nano-enabled food was passed through a three stage (mouth, stomach and small intestine) GIT simulator. Size distributions of nano-enabled food model and digestae at each stage were analyzed by DLS and laser diffraction. TEM and confocal imaging were used to assess morphology of digestae at each phase. Dissolution of Fe2O3 ENM along the GIT was assessed by ICP-MS analysis of supernatants and pellets following centrifugation of digestae. An in vitro transwell triculture epithelial model was used to assess biokinetics and toxicity of ingested Fe2O3 ENM. Translocation of Fe2O3 ENM was determined by ICP-MS analysis of cell lysates and basolateral compartment fluid over time. RESULTS: It was demonstrated that the interactions of iENMs with food and GIT components influenced nanoparticle fate and transport, biokinetics and toxicological profile. Large differences in particle size, charge, and morphology were observed in the model food with and without Fe2O3 and among digestae from different stages of the simulated GIT (mouth, stomach, and small intestine). Immunoflorescence and TEM imaging of the cell culture model revealed markers and morphology of small intestinal epithelium including enterocytes, goblet cells and M cells. Fe2O3 was not toxic at concentrations tested in the digesta. In biokinetics studies, translocation of Fe2O3 after 4 h was <1% and ~2% for digesta with and without serum, respectively, suggesting that use of serum proteins alters iENMs biokinetics and raises concerns about commonly-used approaches that neglect iENM - food-GIT interactions or dilute digestae in serum-containing media. CONCLUSIONS: We present a simple integrated methodology for studying the biokinetics and toxicology of iENMs, which takes into consideration nanoparticle-food-GIT interactions. The importance of food matrix and GIT effects on biointeractions was demonstrated, as well as the incorporation of these critical factors into a cellular toxicity screening model. Standardized food models still need to be developed and used to assess the effect of the food matrix effects on the fate and bioactivity of iENMs since commercial foods vary considerably in their compositions and structures.


Asunto(s)
Ingestión de Alimentos , Compuestos Férricos/toxicidad , Tracto Gastrointestinal/efectos de los fármacos , Nanoestructuras/toxicidad , Nanotecnología , Toxicología/métodos , Administración Oral , Células CACO-2 , Supervivencia Celular/efectos de los fármacos , Digestión , Compuestos Férricos/administración & dosificación , Compuestos Férricos/química , Tracto Gastrointestinal/química , Tracto Gastrointestinal/metabolismo , Tracto Gastrointestinal/patología , Humanos , Modelos Anatómicos , Nanoestructuras/administración & dosificación , Nanoestructuras/química , Reproducibilidad de los Resultados , Medición de Riesgo , Solubilidad , Propiedades de Superficie , Factores de Tiempo , Toxicocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...